These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24388535)

  • 1. Radiosensitization in head and neck cancer: do we have an alternative to platins? Role of taxanes.
    Joseph B; Vishwanath L; Venugopal BK
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):324-8. PubMed ID: 24388535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of docetaxel in the management of squamous cell cancer of the head and neck.
    Glisson BS
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):83-7. PubMed ID: 12108901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxol plus radiation for head and neck cancer.
    Rosenthal DI; Carbone DP
    J Infus Chemother; 1995; 5(2):46-54. PubMed ID: 8521234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel with concurrent radiotherapy in head and neck cancer.
    Nabell L; Spencer S
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):89-93. PubMed ID: 14727247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxanes in cancer of the head and neck.
    Misiukiewicz K; Gupta V; Bakst R; Posner M
    Anticancer Drugs; 2014 May; 25(5):561-70. PubMed ID: 24534821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer.
    Daly ME; Lau DH; Farwell DG; Luu Q; Donald PJ; Chen AM
    Am J Otolaryngol; 2013; 34(6):631-5. PubMed ID: 23954137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.
    Prestwich RJ; Öksüz DÇ; Dyker K; Coyle C; Şen M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e237-43. PubMed ID: 21620580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemoradiotherapy for patients with advanced head and neck cancer].
    Tsukuda M
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoradiotherapy: emerging treatment improvement strategies.
    Milas L; Mason KA; Liao Z; Ang KK
    Head Neck; 2003 Feb; 25(2):152-67. PubMed ID: 12509799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus.
    Hao D; Ritter MA; Oliver T; Browman GP
    Semin Radiat Oncol; 2006 Jan; 16(1):10-9. PubMed ID: 16378902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding role of the medical oncologist in the management of head and neck cancer.
    Choong N; Vokes E
    CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel in the management of patients with head and neck squamous cell carcinoma.
    Bernier J; Vrieling C
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1023-32. PubMed ID: 18588449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin as a radiosensitizer in the treatment of locally advanced head and neck cancer.
    Altundag O; Altundag K; Morandi P; Hanrahan E
    Oral Oncol; 2005 Apr; 41(4):435. PubMed ID: 15792617
    [No Abstract]   [Full Text] [Related]  

  • 14. Concomitant vinorelbine and radiation in head and neck squamous cell carcinoma in vitro.
    Erjala K; Pulkkinen J; Kulmala J; Grénman R
    Acta Oncol; 2004; 43(2):169-74. PubMed ID: 15163165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxanes in combined-modality therapy for solid tumors.
    Choy H
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):23-38. PubMed ID: 10550824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.
    Kovács AF; Mose S; Böttcher HD; Bitter K
    Strahlenther Onkol; 2005 Jan; 181(1):26-34. PubMed ID: 15660190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemotherapy of head and neck cancer.
    De Mulder PH
    Acta Otorhinolaryngol Belg; 1999; 53(3):247-52. PubMed ID: 10635403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy for head and neck cancer: recent data.
    Vokes EE
    Oncologist; 2010; 15 Suppl 3():3-7. PubMed ID: 21036882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer.
    Blanke CD; Choy H; Teng M; Beauchamp RD; Leach S; Roberts J; Washington K; Johnson DH
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):43-52. PubMed ID: 10210539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.
    Tishler RB; Posner MR; Norris CM; Mahadevan A; Sullivan C; Goguen L; Wirth LJ; Costello R; Case M; Stowell S; Sammartino D; Busse PM; Haddad RI
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1036-44. PubMed ID: 16682134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.